$NBIO continued to reduce its liabilities through
Post# of 23572
![Avatar](/images/ProfileImages/734810790_1098_wst.png)
Nascent's CEO Sean Carrick states," The reduction of debt puts Nascent in a stronger position to move forward with the clinical trials which are to begin soon. Further liability management is a primarily objective of the Company."
$HLTY $CTIC $JNJ $MRK $GILD $REGN $MRNA $PFE $ABT $CODX $NVAX $CYDY $GSK $SNY $MRK $INO $VXRT $NNVC $COCP $VIR $NBIO $HTBX $TGRO $DSCR $MMEX $NYXO $DPLS
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)